HomeELDN • NASDAQ
Eledon Pharmaceuticals Inc
add
$2.87
5.13%
After Hours:(0.31%)+0.0088
$2.88
Closed: Oct 8, 4:30:00 PM UTC-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 24.73M | 70.55% |
Net income | -11.22M | 75.02% |
Net profit margin | — | — |
Earnings per share | -0.13 | 87.74% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 107.57M | 28.66% |
Total assets | 144.91M | 20.27% |
Total liabilities | 38.88M | -69.86% |
Total equity | 106.03M | — |
Shares outstanding | 60.00M | — |
Price to book | 1.54 | — |
Return on assets | -40.38% | — |
Return on capital | -55.63% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -11.22M | 75.02% |
Cash from operations | -17.71M | -127.85% |
Cash from investing | 14.96M | 175.12% |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -2.76M | -113.52% |
Free cash flow | -9.24M | -241.68% |
Previous close
$2.73
Day range
$2.73 - $2.88
Year range
$2.32 - $5.54
Market cap
171.86M USD
Avg Volume
884.00K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2004
Headquarters
Website
Employees
31
